Lab Notes: Amicus gets FDA approval for muscle therapy; Aro Biotherapeutics recieves rare pediatric drug designation

In other Philadelphia-area life sciences news, the FDA awarded Aro Biotherapeutics a rare pediatric drug designation for its experimental treatment also for Pompe disease.